Investigation of Instadose Pharma Corp.
Instadose Pharma Corp. (INSD) Misled Investors Causing a Halt in Trading A shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Instadose
Instadose Pharma Corp. (INSD) Misled Investors Causing a Halt in Trading A shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Instadose
Meta Materials Inc. (MMAT) Misled Investors Regarding its Business Prospects A shareholder filed a class action on behalf of all persons who purchased or otherwise acquired the publicly traded
Natera, Inc. (NTRA) Misstated the Accuracy of its Prenatal Tests On January 1, 2022, an article from the New York Times called into question the accuracy of certain noninvasive prenatal
Reata Pharmaceuticals, Inc. (RETA) Made Material Misstatements Regarding the Viability of its Drug Bardoxolone A class action was filed on behalf of all persons and entities that purchased or
Talis Biomedical Corporation (TLIS) Issued a Misleading Registration Statement in Connection with its IPO A shareholder filed a class action on behalf of all persons and entities that purchased
Talkspace, Inc. (TALK) Issued a False and Misleading Proxy in Support of its Merger A class action was filed on behalf of all holders of Talkspace, Inc. (NASDAQ: TALK,
Hyzon Motors Inc. (HYZN) Misrepresented its Customer List and Production Capabilities A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired
Clarivate Plc (CLVT) Made Financial Misstatements On December 27, 2021, Clarivate disclosed in a filing with the U.S. Securities and Exchange Commission that “[o]n December 22, 2021, Clarivate .. .
Applied Therapeutics, Inc. (APLT) Holds Submission of New Drug Application for AT-007 Applied Therapeutics Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, Galactosemia, and diabetic complications.
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.